Tu1966 A Machine-Learning Based Risk Score to Predict Response to Therapy in Crohn's Disease Via Baseline MRE

H. M. Cohn,Cheng Lu,Raj M. Paspulati,Jeffry Katz,Anant Madabhushi,Sharon L. Stein,Fabio Cominelli,Satish Viswanath,Maneesh Dave

DOI: https://doi.org/10.1016/s0016-5085(16)33359-5

IF: 29.4

2016-01-01

Gastroenterology

Abstract:Objective This study was performed to identify gut microbiome patterns in a Chinese population with inflammatory bowel disease (IBD) and to investigate if the specific gut microbiome pattern is associated with the activity of IBD and respond to infliximab treatment.Design We enrolled 51 Chinese patients with ulcerative colitis (UC), 72 with Crohn's disease (CD) and 76 healthy volunteers for cross-sectional comparison of gut microbiota using stool samples.Within the CD patients, 28 individuals were treated with infliximab for 30 weeks and their faecal samples during the treatment were collected as well.Gut microbial communities were analysed by sequencing of the 16S rRNA V4 region, followed by bio-informatical and bio-statistical analysis.These data were compared with Human Microbiome Project results.Results Compared to healthy controls, IBD patients showed increased abundance of Actinobacteria, Proteobacteria, Enterococcus, Streptococcus, Veillonella and decreased abundance of Firmicutes, Bacteroidetes, Prevotella, Roseburia, Ruminococcus, Lachnospira and Clostridiales.CD was especially characterised by reduced abundance of Clostridiales and markedly increased abundance of Fusobacterium.Increased abundance of Actinobacteria and Proteobacteria and reduced abundance of Firmicutes were correlated strongly with CD and UC activity (p<0.05).CD after infliximab treatment, responders (n=21) showed increased abundance of Firmicutes and decreased abundance of Proteobacteria, as well as a significant trend of increased Clostridiales abundance, compared with the relapse group (n=7).Conclusions Our investigation revealed higher abundance of Firmicutes, epecifically Clostridiales, and lower abundance of Proteobacteria are associated with less-severe activity as well as respond to IFX treatment.Our study implied that the gut microbiota is playing a role in the treatment of IBD and restoration of gut microbial homeostasis during treatment could be considered for optimal IBD patients management.